Literature DB >> 29358226

Cesarean Delivery and Risk of Infant Leukemia: A Report from the Children's Oncology Group.

Erin L Marcotte1,2, Michaela R Richardson3, Michelle A Roesler3, Logan G Spector3,2.   

Abstract

Background: Studies have reported increased risks of pediatric acute lymphoblastic leukemia (ALL) among children born by cesarean delivery (CD). However, no previous study has examined the impact of CD on risk of infant leukemia specifically.
Methods: In this study, 443 infants diagnosed with acute leukemia, including both ALL and acute myelogenous leukemia (AML), were identified at Children's Oncology Group institutions between January 1996 and December 2006; 324 controls frequency matched by year of birth were identified though random digit dialing and random selection from U.S. birth registries. Using interview data and, for a subset of participants, medical record data, we analyzed CD overall and by indications that likely resulted in pre-labor CD (PLCD) or emergency CD (ECD). Odds ratios (ORs) and 95% confidence intervals (CIs) for risk of ALL and AML were estimated using multivariable unconditional logistic regression models, adjusted for year of birth, birth weight, and maternal race.
Results: We observed an increased point estimate for the association between CD and ALL (OR, 1.52 and 95% CI, 1.02-2.25). We did not observe an association between CD and AML (OR, 1.02 and 95% CI, 0.64-1.62). In analyses of indication for CD, we observed elevated effect estimates for the associations of both PLCD and ECD and infant ALL.Conclusions: Our analysis suggests an increased risk of infant ALL following CD, including both PLCD and ECD. Altered microbiota colonization may be involved in development of leukemia in infants, but clear biological mechanisms have yet to be determined.Impact: This study provides the first in-depth examination of CD and infant leukemia. Cancer Epidemiol Biomarkers Prev; 27(4); 473-8. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 29358226      PMCID: PMC5884704          DOI: 10.1158/1055-9965.EPI-17-0778

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  43 in total

Review 1.  Cesarean birth in the United States: epidemiology, trends, and outcomes.

Authors:  Marian F MacDorman; Fay Menacker; Eugene Declercq
Journal:  Clin Perinatol       Date:  2008-06       Impact factor: 3.430

2.  Immunoglobulins in intact, immunized, and contaminated axenic mice: study of serum IgA.

Authors:  J Benveniste; G Lespinats; C Adam; J C Salomon
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

3.  Appropriate technology for birth.

Authors: 
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

4.  Mode of delivery and risk of childhood leukemia.

Authors:  Stephen Starko Francis; Steve Selvin; Catherine Metayer; Amelia D Wallace; Vonda Crouse; Theodore B Moore; Joseph L Wiemels; Patricia A Buffler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.254

5.  Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities.

Authors:  Christian M Zwaan; Gertjan J L Kaspers; Rob Pieters; Karel Hählen; Dieuwke R Huismans; Martin Zimmermann; Jochen Harbott; Rosalyn M Slater; Ursala Creutzig; Anjo J P Veerman
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

6.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns.

Authors:  Maria G Dominguez-Bello; Elizabeth K Costello; Monica Contreras; Magda Magris; Glida Hidalgo; Noah Fierer; Rob Knight
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 7.  Leukemia in twins: lessons in natural history.

Authors:  Mel F Greaves; Ana Teresa Maia; Joseph L Wiemels; Anthony M Ford
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

Review 8.  Do bugs control our fate? The influence of the microbiome on autoimmunity.

Authors:  Irene Fung; Jackie P-D Garrett; Anupama Shahane; Mildred Kwan
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

9.  Caesarean delivery and risk of childhood leukaemia: a pooled analysis from the Childhood Leukemia International Consortium (CLIC).

Authors:  Erin L Marcotte; Thomas P Thomopoulos; Claire Infante-Rivard; Jacqueline Clavel; Eleni Th Petridou; Joachim Schüz; Sameera Ezzat; John D Dockerty; Catherine Metayer; Corrado Magnani; Michael E Scheurer; Beth A Mueller; Ana M Mora; Catharina Wesseling; Alkistis Skalkidou; Wafaa M Rashed; Stephen S Francis; Roula Ajrouche; Friederike Erdmann; Laurent Orsi; Logan G Spector
Journal:  Lancet Haematol       Date:  2016-02-27       Impact factor: 18.959

10.  The baby-friendly hospital initiative increases breastfeeding rates in a US neonatal intensive care unit.

Authors:  Anne Merewood; Barbara L Philipp; Neetu Chawla; Sabrina Cimo
Journal:  J Hum Lact       Date:  2003-05       Impact factor: 2.219

View more
  3 in total

1.  Untargeted metabolomics of newborn dried blood spots reveals sex-specific associations with pediatric acute myeloid leukemia.

Authors:  Lauren Petrick; Partow Imani; Kelsi Perttula; Yukiko Yano; Todd Whitehead; Catherine Metayer; Courtney Schiffman; Georgia Dolios; Sandrine Dudoit; Stephen Rappaport
Journal:  Leuk Res       Date:  2021-04-24       Impact factor: 3.715

2.  Paediatric acute lymphoblastic leukaemia and caesarean section: A report from the United Kingdom Childhood Cancer Study (UKCCS).

Authors:  Audrey Bonaventure; Jill Simpson; Pat Ansell; Eve Roman
Journal:  Paediatr Perinat Epidemiol       Date:  2020-05       Impact factor: 3.980

Review 3.  Environmental Risk Factors for Childhood Acute Lymphoblastic Leukemia: An Umbrella Review.

Authors:  Felix M Onyije; Ann Olsson; Dan Baaken; Friederike Erdmann; Martin Stanulla; Daniel Wollschläger; Joachim Schüz
Journal:  Cancers (Basel)       Date:  2022-01-13       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.